Last reviewed · How we verify
NCT04663269
Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy
Phase 4 trial testing 4mg PF Dexamethasone in Kidney Stone in 5 participants. Terminated before completion.
11 September 2020
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 5 |
| Start date | 24 February 2020 |
| Primary completion | 11 September 2020 |
| Estimated completion | 24 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 4mg PF Dexamethasone — full drug profile →
- Control Test — full drug profile →
Conditions studied
- Kidney Stone — all drugs for Kidney Stone →
- Surgery — all drugs for Surgery →
Sponsor
Indiana University
Who can join
18 and older, any sex, with Kidney Stone or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if adding a spinal block (medicine that will numb parts of the body to block pain) along with standard pain control at the incision site will decrease the need for narcotics for pain management and decrease the percentage of patients requiring hospital admission for pain control during postoperative , in-hospital, care after a percutaneous nephrolithotomy (PCNL) (surgery to remove kidney stones), commonly called PERC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04663269
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Stone
Currently open trials in the same condition.
- NCT06944223 — Oxalate and Citrate in Humans - Response to Citrate · NA · recruiting
- NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
- NCT06576661 — Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Be · NA · recruiting
- NCT06210009 — Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease · NA · recruiting
- NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04663269 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 23 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663269.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing